Risk Factors for Hemorrhage of Brain Arteriovenous Malformation

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2019 Jul 31

PMID 31359618

Citations 24

Authors

Sonali S Shaligram

Ethan Winkler

Daniel Cooke

Hua Su

Affiliations

Soon will be listed here.

Abstract

Patients with brain arteriovenous malformation (bAVM) are at risk of intracranial hemorrhage (ICH). Overall, bAVM accounts for 25% of hemorrhagic strokes in adults <50 years of age. The treatment of unruptured bAVMs has become controversial, because the natural history of these patients may be less morbid than invasive therapies. Available treatments include observation, surgical resection, endovascular embolization, stereotactic radiosurgery, or combination thereof. Knowing the risk factors for bAVM hemorrhage is crucial for selecting appropriate therapeutic strategies. In this review, we discussed several biological risk factors, which may contribute to bAVM hemorrhage.

Citing Articles

An Updated Review on the Pathogenesis of Brain Arteriovenous Malformations and Its Therapeutic Targets.

Ota T J Neuroendovasc Ther. 2025; 19(1).

PMID: 39958460 PMC: 11826344. DOI: 10.5797/jnet.ra.2024-0008.

Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition.

Jeong J, Bafor A, Freeman B, Chen P, Park E, Kim E Biomedicines. 2024; 12(8).

PMID: 39200259 PMC: 11351371. DOI: 10.3390/biomedicines12081795.

Predicting intraoperative major blood loss in microsurgery for brain arteriovenous malformations.

Shi J, Xu S, Feng Y, Wei W, Zou Y, Xiong W Front Med (Lausanne). 2024; 11:1446088.

PMID: 39170037 PMC: 11335480. DOI: 10.3389/fmed.2024.1446088.

Defining the Role of Oral Pathway Inhibitors as Targeted Therapeutics in Arteriovenous Malformation Care.

Mansur A, Radovanovic I Biomedicines. 2024; 12(6).

PMID: 38927496 PMC: 11201820. DOI: 10.3390/biomedicines12061289.

Endovascular embolization of Spetzler-Martin Grade I brain arteriovenous malformations: A case report on patient-centered neurointervention.

Rasyid A, Widjaya N, Harris S, Kurniawan M, Mesiano T, Hidayat R Radiol Case Rep. 2024; 19(8):2905-2910.

PMID: 38737177 PMC: 11087695. DOI: 10.1016/j.radcr.2024.03.078.

References

Wong J, Awad I, Kim J . Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000; 46(6):1454-9. DOI: 10.1097/00006123-200006000-00027. View

Wong J, Slomovic A, Ibrahim G, Radovanovic I, Tymianski M . Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-Eligible Unruptured Brain Arteriovenous Malformations. Stroke. 2016; 48(1):136-144. DOI: 10.1161/STROKEAHA.116.014660. View

Natarajan S, Ghodke B, Britz G, Born D, Sekhar L . Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery. 2008; 62(6):1213-25. DOI: 10.1227/01.neu.0000333293.74986.e5. View

Vanlandewijck M, He L, Mae M, Andrae J, Ando K, Del Gaudio F . A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018; 554(7693):475-480. DOI: 10.1038/nature25739. View

Kremer P, Koeleman B, Pawlikowska L, Weinsheimer S, Bendjilali N, Sidney S . Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry. 2014; 86(5):524-9. PMC: 4302044. DOI: 10.1136/jnnp-2013-307276. View

Lv X, Wu Z, Jiang C, Yang X, Li Y, Sun Y . Angioarchitectural characteristics of brain arteriovenous malformations with and without hemorrhage. World Neurosurg. 2011; 76(1-2):95-9. DOI: 10.1016/j.wneu.2011.01.044. View

Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C . Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med. 2010; 16(4):420-8. DOI: 10.1038/nm.2131. View

Potts M, Lau D, Abla A, Kim H, Young W, Lawton M . Current surgical results with low-grade brain arteriovenous malformations. J Neurosurg. 2015; 122(4):912-20. PMC: 4422639. DOI: 10.3171/2014.12.JNS14938. View

Amanzada A, Toppler G, Cameron S, Schworer H, Ramadori G . A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab. Case Rep Oncol. 2011; 3(3):463-70. PMC: 3100268. DOI: 10.1159/000323152. View

10.

Winkler E, Sagare A, Zlokovic B . The pericyte: a forgotten cell type with important implications for Alzheimer's disease?. Brain Pathol. 2014; 24(4):371-86. PMC: 4423607. DOI: 10.1111/bpa.12152. View

11.

Meybodi A, Kim H, Nelson J, Hetts S, Krings T, terBrugge K . Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study. Neurosurgery. 2017; 82(1):35-47. PMC: 5732039. DOI: 10.1093/neuros/nyx168. View

12.

Shen F, Su H, Liu W, Kan Y, Young W, Yang G . Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain. Front Biosci. 2006; 11:3190-8. DOI: 10.2741/2042. View

13.

Shakur S, Amin-Hanjani S, Mostafa H, Charbel F, Alaraj A . Hemodynamic Characteristics of Cerebral Arteriovenous Malformation Feeder Vessels With and Without Aneurysms. Stroke. 2015; 46(7):1997-9. DOI: 10.1161/STROKEAHA.115.009545. View

14.

Argaw A, Gurfein B, Zhang Y, Zameer A, John G . VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A. 2009; 106(6):1977-82. PMC: 2644149. DOI: 10.1073/pnas.0808698106. View

15.

Li C, Hsiao A, Hattangadi-Gluth J, Handwerker J, Farid N . Early Hemodynamic Response Assessment of Stereotactic Radiosurgery for a Cerebral Arteriovenous Malformation Using 4D Flow MRI. AJNR Am J Neuroradiol. 2018; 39(4):678-681. PMC: 7410784. DOI: 10.3174/ajnr.A5535. View

16.

Jafar J, Davis A, Berenstein A, Choi I, Kupersmith M . The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg. 1993; 78(1):60-9. DOI: 10.3171/jns.1993.78.1.0060. View

17.

Sforza D, Kono K, Tateshima S, Vinuela F, Putman C, Cebral J . Hemodynamics in growing and stable cerebral aneurysms. J Neurointerv Surg. 2015; 8(4):407-12. DOI: 10.1136/neurintsurg-2014-011339. View

18.

Riss D, Burian M, Wolf A, Kranebitter V, Kaider A, Arnoldner C . Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial. Head Neck. 2014; 37(6):783-7. DOI: 10.1002/hed.23655. View

19.

Tu J, Stoodley M, Morgan M, Storer K . Responses of arteriovenous malformations to radiosurgery: ultrastructural changes. Neurosurgery. 2006; 58(4):749-58. DOI: 10.1227/01.NEU.0000192360.87083.90. View

20.

Walker E, Su H, Shen F, Degos V, Amend G, Jun K . Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain. Stroke. 2012; 43(7):1925-30. PMC: 3404823. DOI: 10.1161/STROKEAHA.111.647982. View